Synovex

About:

Synovex is a drug developer offering non-immunosuppressive treatments for fibrosis and rheumatoid arthritis.

Description:

Synovex is developing a next generation, non-immunosuppressive treatment for fibrosis that occurs in fibrotic diseases and debilitating cartilage destruction in rheumatoid arthrits.

Total Funding Amount:

$3.5M

Headquarters Location:

Medford, Massachusetts, United States

Founded Date:

2011-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2012-10-11

IPO Status:

Private

Industries: